[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349205-105":59,"doc-detail-349205-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","metabolomics-and-proteomics-analyses-reveal-the-potential-mechanisms-underlying-colorectal-cancer-and-chemotherapy-targets","Metabolomics and proteomics analyses reveal the potential mechanisms underlying colorectal cancer and chemotherapy targets","","Objective is to identify sensitive and specific biomarkers for colorectal cancer (CRC) and clarify its underlying pathophysiology and potential pharmacological targets. Forty cancer tissues and paired paracancer counterparts were profiled using non-targeted metabolomics, while integrated proteomics with machine-learning screening selected featured proteins. Molecular docking validated candidate therapeutic targets. Results show marked metabolic and protein differences by tissue type, CC vs RC, and treatment regimen mFOLFOX6 vs XELOX.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/metabolomics-and-proteomics-analyses-reveal-the-potential-mechanisms-underlying-colorectal-cancer-and-chemotherapy-targets/349205/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/metabolomics-and-proteomics-analyses-reveal-the-potential-mechanisms-underlying-colorectal-cancer-and-chemotherapy-targets/349205.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main objective of the study on CRC?","Question",{"text":113,"@type":114},"To identify sensitive and specific biomarkers for colorectal cancer and to gain deeper insight into its pathophysiology and potential pharmacological targets.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were metabolites and proteins analyzed in the research?",{"text":118,"@type":114},"Non-targeted metabolomics characterized endogenous metabolites and metabolic pathways, while proteomic analysis combined with machine learning screened and identified featured proteins.",{"name":120,"@type":111,"acceptedAnswer":121},"How were potential therapeutic targets validated?",{"text":122,"@type":114},"Molecular docking was used to validate potential therapeutic targets associated with colorectal cancer and chemotherapy regimens.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349205,1791049740,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Li etal. BMC Cancer (2026) 26:656 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15978-4](https://doi.org/10.1186/s12885-026-15978-4)  \nRESEARCH Open Access  \nMetabolomics and proteomics analyses reveal the potiental mechanisms underlying colorectal cancer and chemotherapy targets  \nQianqian Li1, Qin Chen2, Jingwen Chang1, Tingting Fu1, Tianbao Xiao3*, Jiang Chen3* and Tao Yang3*  \nAbstract  \nObjective To identify sensitive, and specific biomarkers for colorectal cancer (CRC) and to obtain deeper insights into the underlying pathophysiology and potential pharmacological targets associated with CRC.  \nMaterials and methods Forty cancer tissues and their paired paracancer counterparts were collected and systematically profiled using non-targeted metabolomics to characterize endogenous metabolites and related metabolic pathways. Proteomic analysis integrated with machine learning approaches was employed to screen and identify featured proteins. Molecular docking analysis was subsequently conducted to validate potential therapeutic targets in CRC.  \nResults Significant differences in metabolic characteristics were observed between cancer and paired paracancer tissues, between colon cancer (CC) and rectal cancer (RC), and between the mFOLFOX6 and XELOX treatment regimens. The differential metabolites identified demonstrated high diagnostic area under the curve values and were capable of serving as endogenous biomarkers for CRC diagnosis, distinguishing CC from RC, and reflecting regimenspecific metabolic responses induced by mFOLFOX6 and XELOX. Additionally, featured proteins distinguishing cancer from paracancer tissues, as well as CC from RC, were successfully validated. Notably, several of these featured proteins were further identified as therapeutic targets associated with the mFOLFOX6 regimen.  \nConclusion This study delineates the comprehensive metabolic and proteomic landscape of CRC, identifies candidate biomarkers for disease diagnosis and subtype differentiation, and reveals potential chemotherapyrelated therapeutic targets. These findings provide a preliminary foundation for developing more precise diagnostic biomarkers and targeted therapeutic approaches for CRC.  \nKeywords Biomarkers, Colorectal cancer, Metabolomics, Proteomics, Therapeutic targets  \n*Correspondence:  \nTianbao Xiao [prof_xiaotianbao@163.com](prof_xiaotianbao@163.com)[ ](prof_xiaotianbao@163.com)Jiang Chen[chenjiang05v92@163.com](chenjiang05v92@163.com)[ ](chenjiang05v92@163.com)Tao Yang [yangtao901212@163.com](yangtao901212@163.com)  \n1College of Clinical Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China  \n2Department of Proctology, Kunming Municipal Hospital of Traditional Chinese Medicine, Kunming, China  \n3Colorectal and Anal Surgery, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](v","cbCaimZeY3gAuO9R","https://ap.wps.com/l/cbCaimZeY3gAuO9R","pdf",9544843,21,"English","# Abstract\n## Objective\n## Materials and methods\n## Results\n## Conclusion\n# Clinical perspectives\n# Introduction","[{\"question\":\"What is the main objective of the study on CRC?\",\"answer\":\"To identify sensitive and specific biomarkers for colorectal cancer and to gain deeper insight into its pathophysiology and potential pharmacological targets.\"},{\"question\":\"How were metabolites and proteins analyzed in the research?\",\"answer\":\"Non-targeted metabolomics characterized endogenous metabolites and metabolic pathways, while proteomic analysis combined with machine learning screened and identified featured proteins.\"},{\"question\":\"How were potential therapeutic targets validated?\",\"answer\":\"Molecular docking was used to validate potential therapeutic targets associated with colorectal cancer and chemotherapy regimens.\"}]","Metabolomics and proteomics analyses reveal the potential mechanisms underlying colorectal cancer and chemotherapy targets | PDF",1790082211,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f5c022cf85b37c9c5253233528fe63e.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70d3833e660152ceb0aa7c2bf9bd0de7.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58a852ba89fb091d109043e2503c77a2.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e13a988602696400d7934c1c325aa3e7.webp",980,1306]